search
Back to results

Virtual Reality for Pain Management in Burn Patients

Primary Purpose

Pain

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Virtual Reality
Sponsored by
Weill Medical College of Cornell University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring Virtual Reality, Pain Management, Anxiety, Depression

Eligibility Criteria

8 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 8 years and older
  • Patients with a burn injury and is in the Burn Unit at New York Presbyterian
  • Awake, alert, ambulatory
  • The burn comprises less than 15% total body surface area (TBSA)
  • The patient does not require conscious sedation such as ketamine for staple removal or wound dressing changes
  • The patient is able to give informed consent

Exclusion Criteria:

  • Diagnosis of a cognitive disorder, psychotic disorder or bipolar I as determined by self-report from previous diagnosis
  • Current opioid abuse

Sites / Locations

  • Weill Cornell MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Virtual Reality

Treatment as Usual

Arm Description

Virtual reality-enhanced distraction using a portable head mounted display during panful events (such as wound dressing changes or physical therapy sessions) in addition to standard of care.

Standard of care during painful event (such as wound dressing changes or physical therapy sessions).

Outcomes

Primary Outcome Measures

Change in Pain
Initial determination of the clinical efficacy of VR in reducing the total pain (determined by the subjective standard 0-10 pain scale) where 0 = no pain and 10 = worst pain.
Change in narcotic dose
Dose of narcotics needed peri-procedure

Secondary Outcome Measures

Change in narcotic dose
Determine if the one-time VR-distraction intervention reduces dose of analgesics for the day after the painful events and the remained of the post-procedure hospitalization
Change in anxiolytics dose
Determine if the one-time VR-distraction intervention reduces anxiolytic dose after painful event
Change in Anxiety Symptoms
Determined by visual analog scales (0-100) where 0 = no anxiety and 100 = worst possible anxiety.
Change in Depressive Symptoms
Determined by visual analog scales (0-100) where 0 = no depression and 100 = worst possible depression.

Full Information

First Posted
December 22, 2020
Last Updated
September 25, 2023
Sponsor
Weill Medical College of Cornell University
search

1. Study Identification

Unique Protocol Identification Number
NCT04685486
Brief Title
Virtual Reality for Pain Management in Burn Patients
Official Title
Virtual Reality for Pain Management in Burn Patients
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2018 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
March 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Weill Medical College of Cornell University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is a randomized proof-of-concept study to assess the efficacy of Virtual Reality (VR) vs standard of care in 50 adult patients in the New York Presbyterian Burn Unit. The participants who are randomized to receive the virtual reality intervention will also receive opioids, which is the standard of care and is known to be effective. Participants will be randomly assigned to two groups. The first group will receive VR during their painful procedure (e.g., wound dressing changes, physical therapy etc.) in addition to the standard of care. The other group will receive standard of care (and no VR).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
Keywords
Virtual Reality, Pain Management, Anxiety, Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Virtual Reality
Arm Type
Experimental
Arm Description
Virtual reality-enhanced distraction using a portable head mounted display during panful events (such as wound dressing changes or physical therapy sessions) in addition to standard of care.
Arm Title
Treatment as Usual
Arm Type
No Intervention
Arm Description
Standard of care during painful event (such as wound dressing changes or physical therapy sessions).
Intervention Type
Other
Intervention Name(s)
Virtual Reality
Intervention Description
Immersive and interactive game played through a portable head-mounted display as a distraction mechanism
Primary Outcome Measure Information:
Title
Change in Pain
Description
Initial determination of the clinical efficacy of VR in reducing the total pain (determined by the subjective standard 0-10 pain scale) where 0 = no pain and 10 = worst pain.
Time Frame
Peri-procedural: 30 minutes before to two hours after the painful event.
Title
Change in narcotic dose
Description
Dose of narcotics needed peri-procedure
Time Frame
Peri-procedural: 30 minutes before to two hours after the painful event.
Secondary Outcome Measure Information:
Title
Change in narcotic dose
Description
Determine if the one-time VR-distraction intervention reduces dose of analgesics for the day after the painful events and the remained of the post-procedure hospitalization
Time Frame
Day 1 of hospitalization to last day of hospitalization (approximately 15 days)
Title
Change in anxiolytics dose
Description
Determine if the one-time VR-distraction intervention reduces anxiolytic dose after painful event
Time Frame
Day 1 of hospitalization to last day of hospitalization (approximately 15 days)
Title
Change in Anxiety Symptoms
Description
Determined by visual analog scales (0-100) where 0 = no anxiety and 100 = worst possible anxiety.
Time Frame
Peri-procedural: 30 minutes before to two hours after the painful event.
Title
Change in Depressive Symptoms
Description
Determined by visual analog scales (0-100) where 0 = no depression and 100 = worst possible depression.
Time Frame
Peri-procedural: 30 minutes before to two hours after the painful event.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 8 years and older Patients with a burn injury and is in the Burn Unit at New York Presbyterian Awake, alert, ambulatory The burn comprises less than 15% total body surface area (TBSA) The patient does not require conscious sedation such as ketamine for staple removal or wound dressing changes The patient is able to give informed consent Exclusion Criteria: Diagnosis of a cognitive disorder, psychotic disorder or bipolar I as determined by self-report from previous diagnosis Current opioid abuse
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Olivia Baryluk, BS
Phone
212-821-0783
Email
olb4002@med.cornell.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
JoAnn Difede, PhD
Organizational Affiliation
Weill Medical College of Cornell University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Weill Cornell Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivia Baryluk, BS
Phone
212-821-0783
Email
olb4002@med.cornell.edu
First Name & Middle Initial & Last Name & Degree
JoAnn Difede, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Virtual Reality for Pain Management in Burn Patients

We'll reach out to this number within 24 hrs